ALFA FinderBSE filing, NSE: RADICO. Summary written from the filing by ALFA Finder's alert engine.
Radico Khaitan Ltd: key numbers
- Share price
- ₹4,515.20
- Market cap
- ₹60,499 Cr
- Revenue (annual)
- ₹6,050 Cr
- Net profit (annual)
- ₹604.5 Cr
- P/E (TTM)
- 76.0×Sector 25.2×
- Promoter holding
- 40.17%-0.02% QoQ
- FII holding
- 19.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Radico Khaitan Ltd
All →Radico Khaitan Other Announcement
Radico Khaitan says its RTA, KFin Technologies, is relocating its corporate office effective December 1, 2026. The registered office stays unchanged, and investors should update their records.
Radico Khaitan ED Probe / Tax Survey
Radico Khaitan disclosed that DRI officials visited its New Delhi office and Rampur plant on October 26, 2026, under the Customs Act. The company reports no current financial or operational impact and is cooperating fully.
Radico Khaitan Management Change
Radico Khaitan appoints CFO Dilip Kumar Banthiya as Executive Director effective October 28, 2026. Saket Somani is elevated to Deputy Chief Financial Officer.
Radico Khaitan Q2 FY27 Results: Net Profit ₹232.3 Cr, Up 66.4% YoY
Radico Khaitan Ltd reported revenue from operations of ₹5,583 Cr (+10.4% YoY) and net profit of ₹232.3 Cr (+66.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹232.3 Cr · +66.4% YoY
Radico Khaitan Other Announcement
Radico Khaitan Limited received an ESG rating score of 69 from NSE Sustainability Ratings and Analytics Limited. This unsolicited rating was based on the company's independent public disclosures.
Radico Khaitan Earnings Call Transcript: Key Takeaways
Radico reports a record quarter led by premiumization, with the P&A segment delivering a staggering 36% volume growth.
- Call
- Guides 25% growth
Other product launch announcements
All →AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum
Restaurant Brands Asia Product Launch
Burger King India launches a limited-edition Avengers: Doomsday Collection across nationwide restaurants. The menu features themed burgers, sides, and merchandise starting at ₹199.
Hero MotoCorp Product Launch
Hero MotoCorp unveiled new motorcycles at EICMA 2026 and started VIDA customer deliveries across Europe. The company also introduced Novus Labs, its future-mobility innovation hub.